Literature DB >> 19447105

Apigenin inhibits proliferation of ovarian cancer A2780 cells through Id1.

Zhao-dong Li1, Xiao-wen Hu, Yu-tian Wang, Jing Fang.   

Abstract

Apigenin, a common dietary flavonoid, has been shown to possess anti-tumor properties. However, the mechanism by which apigenin inhibits cancer cells is not fully understood. Id1 (inhibitor of differentiation or DNA binding protein 1) contributes to tumorigenesis by stimulating cell proliferation, inhibiting cell differentiation and facilitating tumor neoangiogenesis. Elevated Id1 is found in ovarian cancers and its level correlates with the malignant potential of ovarian tumors. Therefore, Id1 is a potential target for ovarian cancer treatment. Here, we demonstrate that apigenin inhibits proliferation and tumorigenesis of human ovarian cancer A2780 cells through Id1. Apigenin suppressed the expression of Id1 through activating transcription factor 3 (ATF3). Our results may elucidate a new mechanism underlying the inhibitory effects of apigenin on cancer cells.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19447105     DOI: 10.1016/j.febslet.2009.05.013

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  11 in total

1.  Eriodictyol inhibits RSK2-ATF1 signaling and suppresses EGF-induced neoplastic cell transformation.

Authors:  Kangdong Liu; Yong-Yeon Cho; Ke Yao; Janos Nadas; Dong Joon Kim; Eun-Jin Cho; Mee-Hyun Lee; Angelo Pugliese; Jishuai Zhang; Ann M Bode; Ziming Dong; Zigang Dong
Journal:  J Biol Chem       Date:  2010-11-22       Impact factor: 5.157

Review 2.  Targeting the PI3K/Akt/mTOR axis by apigenin for cancer prevention.

Authors:  Xin Tong; Jill C Pelling
Journal:  Anticancer Agents Med Chem       Date:  2013-09       Impact factor: 2.505

3.  The dietary compounds resveratrol and genistein induce activating transcription factor 3 while suppressing inhibitor of DNA binding/differentiation-1.

Authors:  Frank G Bottone; Brenda Alston-Mills
Journal:  J Med Food       Date:  2011-05-09       Impact factor: 2.786

Review 4.  Apigenin: a promising molecule for cancer prevention.

Authors:  Sanjeev Shukla; Sanjay Gupta
Journal:  Pharm Res       Date:  2010-03-20       Impact factor: 4.200

5.  Chemical Constituents of the Flowers of Pueraria lobata and Their Cytotoxic Properties.

Authors:  Yejin Kim; Jaeyoon Kim; So-Ri Son; Ji-Young Kim; Jung-Hye Choi; Dae Sik Jang
Journal:  Plants (Basel)       Date:  2022-06-22

6.  Plant flavone apigenin: An emerging anticancer agent.

Authors:  Eswar Shankar; Aditi Goel; Karishma Gupta; Sanjay Gupta
Journal:  Curr Pharmacol Rep       Date:  2017-10-14

7.  Kaempferol targets RSK2 and MSK1 to suppress UV radiation-induced skin cancer.

Authors:  Ke Yao; Hanyong Chen; Kangdong Liu; Alyssa Langfald; Ge Yang; Yi Zhang; Dong Hoon Yu; Myoung Ok Kim; Mee-Hyun Lee; Haitao Li; Ki Beom Bae; Hong-Gyum Kim; Wei-Ya Ma; Ann M Bode; Ziming Dong; Zigang Dong
Journal:  Cancer Prev Res (Phila)       Date:  2014-07-03

8.  Lymphangioleiomyomatosis Biomarkers Linked to Lung Metastatic Potential and Cell Stemness.

Authors:  Gorka Ruiz de Garibay; Carmen Herranz; Alicia Llorente; Jacopo Boni; Jordi Serra-Musach; Francesca Mateo; Helena Aguilar; Laia Gómez-Baldó; Anna Petit; August Vidal; Fina Climent; Javier Hernández-Losa; Álex Cordero; Eva González-Suárez; José Vicente Sánchez-Mut; Manel Esteller; Roger Llatjós; Mar Varela; José Ignacio López; Nadia García; Ana I Extremera; Anna Gumà; Raúl Ortega; María Jesús Plà; Adela Fernández; Sònia Pernas; Catalina Falo; Idoia Morilla; Miriam Campos; Miguel Gil; Antonio Román; María Molina-Molina; Piedad Ussetti; Rosalía Laporta; Claudia Valenzuela; Julio Ancochea; Antoni Xaubet; Álvaro Casanova; Miguel Angel Pujana
Journal:  PLoS One       Date:  2015-07-13       Impact factor: 3.240

9.  Promising activity of Anthemis austriaca Jacq. on the endometriosis rat model and isolation of its active constituents.

Authors:  Mert Ilhan; Zulfiqar Ali; Ikhlas A Khan; Hakkı Taştan; Esra Küpeli Akkol
Journal:  Saudi Pharm J       Date:  2019-06-10       Impact factor: 4.330

10.  Emerging glycolysis targeting and drug discovery from chinese medicine in cancer therapy.

Authors:  Zhiyu Wang; Neng Wang; Jianping Chen; Jiangang Shen
Journal:  Evid Based Complement Alternat Med       Date:  2012-07-12       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.